Invitae study shows therapy informed by genetic testing reduces seizures in some patients with epilepsy

A study by Invitae reveals genetic testing in epilepsy patients leads to clinical management changes in half, improving outcomes in 75%. It supports universal genetic testing for epilepsy to enhance care and outcomes, emphasizing precision medicine's role in treatment.